Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients

Clinical trial NCT07695090 · RECRUITING

Trial details

NCT number: NCT07695090
Sponsor: Qanatpharma AG
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction

Start date: 2026-07-01
Primary completion: 2027-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.